Cameroon’s health ministry has suspended administration of AstraZeneca’s COVID-19 vaccine it was scheduled to receive on March 20 as part of the global vaccines sharing scheme COVAX.
The ministry said in a statement that March 18 that the suspension was for precaution and prudence.
It gave no further reasons for the decision or if it will go ahead and take delivery of its share of the vaccine.
Several countries have resumed use of shots on Friday after the European Union and British regulators said the benefits outweighed any risks after reports of rare instances of blood clotting that temporarily halted inoculations.
Meanwhile, South Africa has concluded the sale of AstraZeneca COVID-19 vaccines it had acquired but did not use to other African Union member states, the health ministry said on Sunday.
The country had paused AstraZeneca vaccinations last month because of a small trial showing the shot offered minimal protection against mild to moderate illness caused by the dominant local coronavirus variant.
At the time, South Africa had received 1 million AstraZeneca doses from the Serum Institute of India and the delivery of another 500,000 was pending.
“The first batch of vaccines that is being delivered will benefit 9 member states and the balance will be collected this week to be delivered to 5 other member states.”
The statement made no mention of prices and did not name the countries that had purchased the vaccines.
After pausing the roll-out of the AstraZeneca vaccine, South Africa started inoculating healthcare workers with Johnson & Johnson shots in a research study.
— The Newz Post (@Newzug) March 21, 2021